Blood News and Research

RSS

Irregularities in sleep timing and duration linked with increased risk of hypertension

A study of more than two million nights of sleep and blood pressure data found that irregularities in sleep timing and duration were associated with an increased risk of hypertension.

8 Jun 2022

Study confirms benefits and safety of goat milk-based infant formula

Researchers discuss the efficacy and safety of a goat milk-based formulation in infants.

8 Jun 2022

New study into sepsis could save children’s lives around the world

A clinical study examining new ways of treating children with sepsis - using vitamin C and steroids alongside antibiotics - could save children's lives around the world.

8 Jun 2022

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Before a patient can undergo T cell therapy designed to target cancerous tumors, the patient's entire immune system must be destroyed with chemotherapy or radiation. The toxic side effects are well known, including nausea, extreme fatigue and hair loss.

8 Jun 2022

Research suggests two protein coding genes can predict severe COVID-19

In a recent study posted to the medRxiv* pre-print server, researchers demonstrated that two genes, GTPase, IMAP Family Member 7 (GIMAP7), and sphingosine-1-phosphate receptor 2 (S1PR2), have the potential to predict severe coronavirus disease 2019 (COVID-19) with ~90% accuracy.

8 Jun 2022

New therapeutic avoids major allergic reactions while maintaining therapeutic activity

Several years ago, a promising therapeutic using stem cell factor (SCF) emerged that could potentially treat a variety of ailments, such as ischemia, heart attack, stroke and radiation exposure.

8 Jun 2022

Higher levels of optimism may promote health and longevity in diverse racial and ethnic groups

Higher levels of optimism were associated with longer lifespan and living beyond age 90 in women across racial and ethnic groups in a study led by researchers at Harvard T.H. Chan School of Public Health.

8 Jun 2022

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

A molecule in mosquito spit has been identified as a potential new target for vaccination against a range of diseases for which there is no protection or medicine.

8 Jun 2022

UChicago Medicine launches new study to explore cancer causes and prevention

The University of Chicago Medicine hopes to recruit 50,000 people to participate in a new national study designed to explore the causes of cancer and learn more about how to prevent it.

8 Jun 2022

New technology may enable rapid diagnosis of Ebola virus

A new tool can quickly and reliably identify the presence of Ebola virus in blood samples, according to a study by researchers at Washington University School of Medicine in St. Louis and colleagues at other institutions.

8 Jun 2022

Diet rich in polyphenols can prevent inflammation in the elderly

Polyphenols in the foods that we eat can prevent inflammation in older people, since they alter the intestinal microbiota and induce the production of the indole 3-propionic acid (IPA), a metabolite derived from the degradation of tryptophan due to intestinal bacteria.

8 Jun 2022

More than 70% of bowel cancer patients are diagnosed outside of traditional screening programs

More than 70 percent of patients with bowel cancer are not diagnosed using official screening programs meaning diagnoses are often made late, when the cancer is at an advanced stage, according to new research from the University of Surrey.

8 Jun 2022

Einstein researchers receive $3.5 million NIH grant to study the effects of SARS-CoV-2 on the brain

Albert Einstein College of Medicine researchers have been awarded a five-year, $3.5 million grant from the National Institutes of Health to study the effects of COVID-19 on the brains of adults who had mild or asymptomatic infection.

8 Jun 2022

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more likely to be undertreated for several cardiovascular risk factors: hypertension (also called high blood pressure), diabetes and high cholesterol, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

8 Jun 2022

Ayurvedic medicine is effective in blood sugar control in patients with type 2 diabetes, study finds

A new study, led by experts at the University of Nottingham, has found that several traditional medicines commonly used in South Asia, are effective in maintaining blood sugar levels in patients with type 2 diabetes.

8 Jun 2022

New diagnostic procedure could help start optimal stroke treatment in a timely manner

A blood clot in the brain that blocks the supply of oxygen can cause an acute stroke. In this case, every minute counts.

8 Jun 2022

Immune protein could be a target of future treatments for alcohol use disorder

The anxiety that occurs during withdrawal from excessive alcohol use, and contributes to relapse, may be driven in part by the release of an immune protein in the brain, according to a new study from scientists at Scripps Research.

8 Jun 2022

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

Micronutrient deficiencies can promote inflammation and render the immune system particularly sensitive to allergenic substances.

8 Jun 2022

Cofilin could be a potential target for mitigating atherosclerosis at early stage, finds study

A joint research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and Queen Mary University of London (QMUL) has discovered the molecular mechanisms of how pathological condition-mimicking mechanical stimuli lead to the early progression of atherosclerosis, a leading cause of vascular disease worldwide.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Blood News and Research

Irregularities in sleep timing and duration linked with increased risk of hypertension

Study confirms benefits and safety of goat milk-based infant formula

New study into sepsis could save children’s lives around the world

Synthetic IL-9 receptor allows T cells to fight cancer without the need for chemo or radiation

Research suggests two protein coding genes can predict severe COVID-19

New therapeutic avoids major allergic reactions while maintaining therapeutic activity

Higher levels of optimism may promote health and longevity in diverse racial and ethnic groups

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

UChicago Medicine launches new study to explore cancer causes and prevention

New technology may enable rapid diagnosis of Ebola virus

Diet rich in polyphenols can prevent inflammation in the elderly

More than 70% of bowel cancer patients are diagnosed outside of traditional screening programs

Einstein researchers receive $3.5 million NIH grant to study the effects of SARS-CoV-2 on the brain

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

Ayurvedic medicine is effective in blood sugar control in patients with type 2 diabetes, study finds

New diagnostic procedure could help start optimal stroke treatment in a timely manner

Immune protein could be a target of future treatments for alcohol use disorder

Targeted dietary measures can reduce the symptom burden in allergic reactions, trial shows

Cofilin could be a potential target for mitigating atherosclerosis at early stage, finds study

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News